BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31510013)

  • 1. MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer.
    Vychytilova-Faltejskova P; Svobodova Kovarikova A; Grolich T; Prochazka V; Slaba K; Machackova T; Halamkova J; Svoboda M; Kala Z; Kiss I; Slaby O
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
    Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
    Li W; Chang J; Tong D; Peng J; Huang D; Guo W; Zhang W; Li J
    Oncotarget; 2017 May; 8(22):35783-35791. PubMed ID: 28415758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients.
    Stratmann J; Wang CJ; Gnosa S; Wallin A; Hinselwood D; Sun XF; Zhang H
    BMC Cancer; 2011 Aug; 11():345. PubMed ID: 21827717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
    Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
    Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer.
    Vychytilova-Faltejskova P; Pesta M; Radova L; Liska V; Daum O; Kala Z; Svoboda M; Kiss I; Slaby O
    Cancer Genomics Proteomics; 2016; 13(4):311-6. PubMed ID: 27365381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.
    Cho SH; Ko JJ; Kim JO; Jeon YJ; Yoo JK; Oh J; Oh D; Kim JW; Kim NK
    PLoS One; 2015; 10(7):e0131125. PubMed ID: 26147304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.
    Mokutani Y; Uemura M; Munakata K; Okuzaki D; Haraguchi N; Takahashi H; Nishimura J; Hata T; Murata K; Takemasa I; Mizushima T; Doki Y; Mori M; Yamamoto H
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):599-608. PubMed ID: 26868958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer.
    Chorti A; Bangeas P; Papavramidis TS; Tsoulfas G
    Microrna; 2018; 7(3):167-177. PubMed ID: 29793419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
    Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
    Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.
    Kim YK; Kim B; Kim VN
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1881-9. PubMed ID: 26976605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
    Mullany LE; Herrick JS; Wolff RK; Slattery ML
    Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic characterization of liver metastases from colorectal cancer patients.
    Sayagués JM; Corchete LA; Gutiérrez ML; Sarasquete ME; Del Mar Abad M; Bengoechea O; Fermiñán E; Anduaga MF; Del Carmen S; Iglesias M; Esteban C; Angoso M; Alcazar JA; García J; Orfao A; Muñoz-Bellvis L
    Oncotarget; 2016 Nov; 7(45):72908-72922. PubMed ID: 27662660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.